AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Adial Pharmaceuticals, Inc.
Video analysis: ADIL
All videosNo video analysis for this stock yet. Request one from our team.
News: ADIL
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GLEN ALLEN, Va., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company's Compensation Committee has granted a new employee stock option to purchase 307,814 shares of common stock as an inducement to such person becoming an employee of the Company.
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
Completed acquisition of Azora Therapeutics, adding AT177, a fully synthetic, oral, colon-targeted aryl hydrocarbon receptor (“Ahr”) agonist in development for ulcerative colitis, to its pipeline
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company's Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company's newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026.
Similar companies
-
NeuroSense Therapeutics Ltd.
NRSN
·
NASDAQ
Compare
-
Acurx Pharmaceuticals, Inc.
ACXP
·
NASDAQ
Compare
-
Matinas BioPharma Holdings, Inc.
MTNB
·
New York Stock Exchange Arca
Compare
-
Brainstorm Cell Therapeutics Inc.
BCLI
·
Other OTC
Compare
-
Aprea Therapeutics, Inc.
APRE
·
NASDAQ
Compare
-
HCW Biologics Inc.
HCWB
·
NASDAQ
Compare